Hoba Therapeutics ApS
Private limited companyCVR 38231170FrederiksbergActive
Hoba Therapeutics ApS is a private limited company, based in Frederiksberg, active in research and experimental development on natural sciences and engineering, founded in 2016. The company made a loss in both 2025 and 2026, most recently DKK 67.7m. Equity fell to DKK 1.1m in 2026. 8 other companies in the database are registered at the same address.
Key figures · financial year 2026
Gross profit−DKK 61.7m−60.9% vs. 2025
Net profit−DKK 67.7m−57.4% vs. 2025
EquityDKK 1.1m−95.6% vs. 2025
Employees3latest month from CVR
What has changed
calculated from recorded figures and datesFinancials: 2026 against 2025
- The loss grew: from DKK 43m to DKK 67.7m (2025 → 2026).
- Equity fell 96% (2025 → 2026), to DKK 1.1m.
Employees
- 4 fewer employees than a year earlier: 3 (07/2026) against 7 (07/2025).
Management and owners, last 24 months
- New in management: Gonçalo Nuno Nunes da Silva Rebelo de Andrade (ceo, 01/04/2026), Gonçalo Nuno Nunes da Silva Rebelo de Andrade (chair of the board, 01/06/2026) and Kuang He (board member, 21/01/2025) (+1).
- Stepped down: Torsten Meldgaard Madsen (ceo, 19/09/2025), Camilla Petrycer Hansen (board member, 08/04/2026) and Gonçalo Nuno Nunes da Silva Rebelo de Andrade (board member, 31/05/2026) (+4).
- New owners registered: EIC Fund (01/09/2025) and Indaco Venture Partners SGR S.p.A. (01/09/2025).
- No longer registered as owner: EIC Fund (31/08/2025) and Indaco Venture Partners SGR S.p.A. (31/08/2025).
Registrations, last 24 months
- 13/05/2026: Moved to Nordre Fasanvej 215, 2000 Frederiksberg
- 01/09/2025: Share capital changed from 2,373,600 DKK to 2,991,195 DKK
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2021–2026 · amounts in DKK thousandEquity and net profit
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | 0 | not stated | not stated | not stated | not stated | – |
| Gross profit | 1,393 | −7,182 | −9,430 | −20,860 | −38,348 | −61,711 | −60.9% |
| Operating profit (EBIT) | −1,511 | −10,182 | −15,410 | −30,650 | −48,700 | −72,294 | −48.4% |
| Profit before tax | −3,001 | −12,706 | −18,027 | −33,307 | −48,508 | −73,194 | −50.9% |
| Net profit | −1,945 | −10,899 | −13,930 | −27,807 | −43,008 | −67,694 | −57.4% |
| Total assets | 36,461 | 19,646 | 15,288 | 91,476 | 46,100 | 15,583 | −66.2% |
| Equity | 8,184 | −18,975 | −32,905 | 69,070 | 26,062 | 1,144 | −95.6% |
| Liabilities | 25,432 | 38,621 | 48,193 | 22,406 | 20,038 | 14,439 | −27.9% |
| Cash and cash equivalents | 14,023 | 1,174 | 5,430 | 83,191 | 37,104 | 5,669 | −84.7% |
| Average number of employees | 3 | 3 | 6 | 8 | 8 | 7 | −12.5% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2023, 2024, 2025, 2026: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2026 figuresLoss for 6 years in a row
Net result has been negative in 2021–2026.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
Equity fell sharply
Equity fell 96% from 2025 to 2026 (DKK 26.1m to DKK 1.1m).
How is this calculated?
Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.
Low equity ratio
Equity makes up 7% of total assets in 2026.
How is this calculated?
Equity ÷ total assets is below 10% in the latest annual report. Banks, insurers and some industries naturally have a low ratio.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2026 | 01/04/2025 – 31/03/2026 | 07/10/2026 | The company | PDF not statedXBRL |
| 2025 | 01/04/2024 – 31/03/2025 | 15/09/2025 | The company | PDF not statedXBRL |
| 2024 | 01/04/2023 – 31/03/2024 | 30/08/2024 | The company | PDFXBRL |
| 2023 | 01/04/2022 – 31/03/2023 | 02/10/2023 | The company | PDFXBRL |
| 2022 | 01/04/2021 – 31/03/2022 | 14/10/2022 | The company | PDFXBRL |
| 2021 | 01/04/2020 – 31/03/2021 | 31/08/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Gross profit−DKK 61.7mNo. 417 of 421
Better than 1% of the companies in the industry
EquityDKK 1.1mNo. 238 of 431
Better than 45% of the companies in the industry
Number of employees3No. 173 of 431
Better than 60% of the companies in the industry
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 69,734of 69,742 Better than 0% | No. 31,882of 69,964 Better than 54% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 323of 323 Better than 0% | No. 150of 329 Better than 55% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 33,578of 33,588 Better than 0% | No. 14,524of 33,687 Better than 57% |
| All companies of type ApS66,508 companies in the comparison | No. 66,373of 66,379 Better than 0% | No. 27,793of 66,505 Better than 58% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineeringGross profit
- Hoba Therapeutics ApS−DKK 61.7m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
Net profit
- Hoba Therapeutics ApS−DKK 67.7m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
Equity
- Hoba Therapeutics ApSDKK 1.1m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
Employees
- Hoba Therapeutics ApS3
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership RegisterOwners
- Novo Holdings A/S33.33%
- Eir Ventures I AB10%
- Danmarks Eksport- og Investeringsfond10%
- MIJ Biotech-Global Limited Partnership5%
- EIC Fund20%
- Indaco Venture Partners SGR S.p.A.10%
Hoba Therapeutics ApS
Management
3 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Gonçalo Nuno Nunes da Silva Rebelo de Andrade | CEO | 01/04/2026 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Gunnar Magnus Severus Modée Persson | Board member | 10/09/2024 |
| Gonçalo Nuno Nunes da Silva Rebelo de Andrade | Chair of the board | 01/06/2026 |
- Founders
- Nsgene A/S
Former management (16)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Teit Eliot Johansen | Board member | 28/11/2016 | 08/12/2023 |
| Lene Gerlach | Board member | 28/11/2016 | 19/11/2018 |
| Morten Døssing | Director | 28/11/2016 | 01/01/2017 |
| Morten Døssing | Board member | 28/11/2016 | 08/12/2023 |
| Amanda Hayward | Chair of the board | 28/11/2016 | 01/03/2024 |
| Kenneth Ahrend Petersen | CEO | 01/01/2017 | 01/07/2020 |
| Steen Palle Petersen | Board member | 19/11/2018 | 31/01/2020 |
| Thor Jespersen | Board member | 31/01/2020 | 28/06/2022 |
| Torsten Meldgaard Madsen | CEO | 01/07/2020 | 19/09/2025 |
| Camilla Petrycer Hansen | Board member | 24/08/2021 | 08/04/2026 |
| Lene Gerlach | Board member | 28/06/2022 | 02/09/2024 |
| Gonçalo Nuno Nunes da Silva Rebelo de Andrade | Board member | 08/12/2023 | 31/05/2026 |
| Marie Allen Schroeder | Board member | 08/12/2023 | 21/01/2025 |
| Jean Marcel André Combalbert | Chair of the board | 01/03/2024 | 31/05/2026 |
| Kuang He | Board member | 21/01/2025 | 08/04/2026 |
| Jean Marcel André Combalbert | CEO | 19/09/2025 | 31/03/2026 |
Signing rule: Selskabet tegnes af bestyrelsens formand i forening med den adm. direktør eller af den samlede bestyrelse.
Address and production units
1 active production unitsNordre Fasanvej 215
2000 Frederiksberg
Frederiksberg Municipality · Postcode 2000
Other companies at the address (8)
- Sparrow Quantum ApSManufacture of computers and peripheral equipment
- Adcendo ApSResearch and experimental development on natural sciences and engineering
- Hemab ApSManufacture of pharmaceutical preparations
- Orbis Medicines ApSResearch and experimental development on natural sciences and engineering
- Minervax ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Hoba Therapeutics ApS | Nordre Fasanvej 215, 2000 Frederiksberg | 2 | 1021979690 |
Purpose
Selskabets formål er forskning, udvikling og kommercialisering af lægemidler.
The purpose is quoted from the register in Danish.
Changes year by year
82 registered events112016
72017
72018
02019
42020
22021
62022
202023
52024
112025
92026
20269 changesaccounts 1 · management 7 · address 1
- AccountsAnnual report for 2026 published
- ManagementGonçalo Nuno Nunes da Silva Rebelo de Andrade appointed chair of the board
- ManagementJean Marcel André Combalbert stepped down as chair of the board
- ManagementGonçalo Nuno Nunes da Silva Rebelo de Andrade stepped down as board member
- AddressMoved to Nordre Fasanvej 215, 2000 Frederiksberg
- ManagementKuang He stepped down as board member
- ManagementCamilla Petrycer Hansen stepped down as board member
- ManagementGonçalo Nuno Nunes da Silva Rebelo de Andrade appointed ceo
- ManagementJean Marcel André Combalbert stepped down as ceo
202511 changesmanagement 4 · accounts 1 · capital 1 · ownership 4 · industry 1
- ManagementJean Marcel André Combalbert appointed ceo
- ManagementTorsten Meldgaard Madsen stepped down as ceo
- AccountsAnnual report for 2025 published
- CapitalShare capital changed from 2,373,600 DKK to 2,991,195 DKK
- OwnershipEIC Fund registered as owner (20%)
- OwnershipIndaco Venture Partners SGR S.p.A. registered as owner (10%)
- OwnershipIndaco Venture Partners SGR S.p.A. is no longer registered as owner
- OwnershipEIC Fund is no longer registered as owner
- ManagementKuang He appointed board member
- ManagementMarie Allen Schroeder stepped down as board member
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20245 changesmanagement 4 · accounts 1
- ManagementGunnar Magnus Severus Modée Persson appointed board member
- ManagementLene Gerlach stepped down as board member
- AccountsAnnual report for 2024 published
- ManagementJean Marcel André Combalbert appointed chair of the board
- ManagementAmanda Hayward stepped down as chair of the board
202320 changescapital 1 · management 4 · ownership 14 · accounts 1
- CapitalShare capital changed from 315,384 DKK to 2,373,600 DKK
- ManagementGonçalo Nuno Nunes da Silva Rebelo de Andrade appointed board member
- ManagementMarie Allen Schroeder appointed board member
- ManagementTeit Eliot Johansen stepped down as board member
- ManagementMorten Døssing stepped down as board member
- OwnershipDanmarks Eksport- og Investeringsfond registered as owner (10%)
- OwnershipEir Ventures I AB registered as owner (10%)
- OwnershipNovo Holdings A/S registered as owner (33.33%)
- OwnershipIndaco Venture Partners SGR S.p.A. registered as owner (5%)
- OwnershipEIC Fund registered as owner (15%)
- OwnershipMIJ Biotech-Global Limited Partnership registered as owner (5%)
- OwnershipTeit Eliot Johansen is no longer registered as owner
- OwnershipBOK Holding A/S is no longer registered as owner
- OwnershipSøren Sylvester Skjærbæk is no longer registered as owner
- OwnershipDanmarks Eksport- og Investeringsfond is no longer registered as owner
- OwnershipEir Ventures I AB is no longer registered as owner
- OwnershipNovo Holdings A/S is no longer registered as owner
- AccountsAnnual report for 2023 published
- OwnershipDanmarks Eksport- og Investeringsfond registered as owner (5%)
- OwnershipVÆKSTFONDEN is no longer registered as owner
20226 changesaccounts 1 · management 2 · ownership 3
- AccountsAnnual report for 2022 published
- ManagementLene Gerlach appointed board member
- ManagementThor Jespersen stepped down as board member
- OwnershipEir Ventures I AB registered as owner (5%)
- OwnershipVÆKSTFONDEN registered as owner (5%)
- OwnershipUddannelses- og Forskningsstyrelsen is no longer registered as owner
20212 changesaccounts 1 · management 1
- AccountsAnnual report for 2021 published
- ManagementCamilla Petrycer Hansen appointed board member
20204 changesmanagement 4
- ManagementTorsten Meldgaard Madsen appointed ceo
- ManagementKenneth Ahrend Petersen stepped down as ceo
- ManagementThor Jespersen appointed board member
- ManagementSteen Palle Petersen stepped down as board member
20187 changesmanagement 2 · capital 1 · ownership 4
- ManagementSteen Palle Petersen appointed board member
- ManagementLene Gerlach stepped down as board member
- CapitalShare capital changed from 253,846 DKK to 315,384 DKK
- OwnershipTeit Eliot Johansen registered as owner (15%)
- OwnershipUddannelses- og Forskningsstyrelsen registered as owner (15%)
- OwnershipTeit Eliot Johansen is no longer registered as owner
- OwnershipUddannelses- og Forskningsstyrelsen is no longer registered as owner
20177 changesownership 4 · address 1 · management 2
- OwnershipTeit Eliot Johansen registered as owner (20%)
- OwnershipTeit Eliot Johansen is no longer registered as owner
- AddressMoved to Ole Maaløes Vej 3, 2200 København N
- ManagementKenneth Ahrend Petersen appointed ceo
- ManagementMorten Døssing stepped down as director
- OwnershipUddannelses- og Forskningsstyrelsen registered as owner (10%)
- OwnershipStyrelsen for Forskning og Uddannelse is no longer registered as owner
201611 changesfounded 1 · management 5 · ownership 5
- FoundedRegistered as Hoba Therapeutics ApS
- ManagementTeit Eliot Johansen appointed board member
- ManagementLene Gerlach appointed board member
- ManagementAmanda Hayward appointed chair of the board
- ManagementMorten Døssing appointed board member
- ManagementMorten Døssing appointed director
- OwnershipNovo Holdings A/S registered as owner (33.33%)
- OwnershipStyrelsen for Forskning og Uddannelse registered as owner (10%)
- OwnershipTeit Eliot Johansen registered as owner (20%)
- OwnershipBOK Holding A/S registered as owner (5%)
- OwnershipSøren Sylvester Skjærbæk registered as owner (5%)
Related companies
Same industry in Frederiksberg
- Adcendo ApS49 employees
- Orbis Medicines ApS32 employees
- Minervax ApS28 employees
- Inprother ApS18 employees
- Acesion Pharma ApS16 employees
- Kost Studio ApS11 employees
Same people in management
- Netic A/Svia Thor Jespersen
- Actas A/Svia Søren Sylvester Skjærbæk
- NTG Nordic Transport Group A/Svia Teit Eliot Johansen
- NRGI A.m.b.a.via Søren Sylvester Skjærbæk
- TinyMobileRobots ApSvia Thor Jespersen
- Aalborg Energie Technik A/Svia Thor Jespersen
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.